Adj. Prof. UCSF
Principle, NDA Partners/Treximo
UCSF
NDA Partners/Treximo
Carl Peck MD, is Adj. Professor, UCSF and is a Cofounder and Expert Consultant of NDA Partners/Treximo. His career long interest in quantitative clinical pharmacology is documented in more than 175 published peer-reviewed papers and chapters. As former Director of the FDA Center for Drug Evaluation and Research (CDER), he championed incorporation of advanced quantitative clinical pharmacolgy approaches in regualatory science and medical product development. His contributions have been recognized via an Honorary degree from Sweden's Uppsala University and receipt of the 1994 ASCPT Rawls Palmer Progress in Medicine Award, the 1999 FDA Distinguished Alumnus Award, 2012 ASCPT Gary Neal Prize for Innovation in Drug Development, the 2017 ASCPT Sheiner-Beal Pharmacometrics Award and the 2018 Gary Levy Memorial Lectureship. He has been a member of ASCPT for more than 45 years and was it President in 1999.
Disclosure information not submitted.
Wednesday, March 16, 2022
12:00 PM – 1:00 PM ET